Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous selected renal cells (1 trial)
renal autologous cell therapy (1 trial)
Congenital Abnormalities (Phase 1)
Kidney Diseases (Phase 2)
Renal Insufficiency, Chronic (Phase 2)
Trials (2 total)
Trial APIs (2 total)